View Agent
| Agent Info | |
| Agent: | alectinib |
| Synonyms: | CH5424802/RO5424802 |
| Drug Status For Certain Diseases: | NA |
| Classification: | 2nd-generation,novel, highly selective, and potent ALK inhibitor that has shown clinical activity in patients with crizotinib-naive ALK-rearranged non-small-cell lung cancer |
| Target: | ALK L1196M G1269A C1156Y F1174L |
| KEGG Pathway: | MAPK pathway PI3K-AKT pathway JAK-STAT pathway |
| Wiki Pathway: | NA |